Locations:
Search
Phase 2 trials investigate sitagliptin and methimazole as adjuvant therapies
Advances in genomics, spinal fluid analysis, wearable-based patient monitoring and more
An update on the technology from the busiest Gamma Knife center in the Americas
Novel approach begins reinnervation before tumor resection, preserving a young woman’s smile
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Researchers use AI tools to compare clinical events with continuous patient monitoring
Combining dual inhibition with anti-PD1 therapy yielded >60% rate of complete tumor regression
A range of pituitary tumor-related conditions all benefit from a multidisciplinary approach
Cleveland Clinic researchers pursue answers on basic science and clinical fronts
Insights from 15 years of experience of Cleveland Clinic’s spine tumor board
Study demonstrates its role in tumor lethality, raises prospect of therapeutic targets
Advertisement
Advertisement